Shibuya Corporation highlights its Vial Filling Systems, established aseptic solutions engineered to support reliable performance across multiple products and every stage of pharmaceutical vial preparation and filling.
Sequana Medical has announced strong commercial US progress with implants of the alfapump System having been completed at five centres since launch in Q4 2025.
Quotient Sciences has extended commercial supply partnership with Ipsen to manufacture a treatment for Fibrodysplasia Ossificans Progressiva (FOP), an ultra-rare disease affecting fewer than 1,000 people worldwide.
Asahi Kasei Pharma announced that it has strengthened its drug discovery pipeline through an exclusive global license agreement regarding novel lead compounds for a single target with Alchemedicine.
Shibuya Hoppmann highlights its FT-40 RD and FT-50 RD Centrifugal Feeders, designed to deliver consistent, high-speed part feeding with durable construction and easy integration into automated production environments.
INTERPHEX WEEK TOKYO 2026, one of Japan’s largest and most influential trade shows for the pharmaceutical and biotechnology sectors, is set to return 20-22nd May at Makuhari Messe with an expanded showcase expected to surpass its 2025 performance.
Aylward Enterprises highlights the TCM Tablet Counter, engineered to provide 100% count verification and reject-on-the-fly performance for pharmaceutical, nutraceutical, and healthcare packaging lines.
MGS, a global healthcare Contract Development and Manufacturing Organisation, has announced the acquisition of Knudsen Plast A/S, a premier Denmark-based injection moulder with more than 40 years of dedicated healthcare manufacturing experience.
Thermo Fisher Scientific introduces the Thermo Scientific Sequential Protein/DNA/RNA Extraction Kit, a sample preparation solution designed to enable the sequential extraction of protein, DNA and RNA from a single sample.
Lonza has strengthened its Advanced Synthesis offering to increase phase-appropriate support for the discovery and development of antibody-drug conjugates (ADCs) and other bioconjugates.
